5,940 Shares of Danaher Corporation $DHR Bought by Bill Few Associates Inc.

Bill Few Associates Inc. purchased a new stake in Danaher Corporation (NYSE:DHR) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,940 shares of the conglomerate’s stock, valued at approximately $1,316,000.

Several other hedge funds also recently added to or reduced their stakes in DHR. BlackRock Inc. purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $10,492,520,000. State Street Corp grew its position in shares of Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after buying an additional 472,608 shares during the last quarter. Wellington Management Group LLP raised its stake in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC acquired a new stake in Danaher during the 2nd quarter worth $1,456,317,000. Finally, Generation Investment Management LLP purchased a new stake in Danaher in the second quarter valued at $1,287,949,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

NYSE DHR traded up $2.69 during trading on Friday, reaching $220.15. The company’s stock had a trading volume of 3,934,329 shares, compared to its average volume of 4,457,726. The business’s fifty day moving average price is $210.88 and its 200-day moving average price is $194.44. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market cap of $154.76 billion, a price-to-earnings ratio of 39.10, a P/E/G ratio of 2.72 and a beta of 0.76.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the firm earned $0.77 earnings per share. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. As a group, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Analyst Ratings Changes

Several equities analysts have issued reports on DHR shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Stifel Nicolaus dropped their price target on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler started coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, Guggenheim boosted their price objective on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $235.23.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.